WallStreetZenWallStreetZen

NASDAQ: MXCT
Maxcyte Inc Earnings & Revenue

MXCT past revenue growth

How has MXCT's revenue growth performed historically?
Company
-6.72%
Industry
9.25%
Market
17.15%
MXCT's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
MXCT's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance

MXCT earnings and revenue history

Current Revenue
$41.3M
Current Earnings
-$37.9M
Current Profit Margin
-91.8%

MXCT Return on Equity

Current Company
-15.9%
Current Industry
10.5%
Current Market
188%
MXCT's Return on Equity (-15.9%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when MXCT announces earnings.

MXCT Return on Assets

Current Company
-13.9%
Current Industry
5.3%
MXCT is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

MXCT Return on Capital Employed

Current Company
-15.14%
Current Industry
8.3%
MXCT has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

MXCT vs Medical Device Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
MXCT$41.29M-$33.36M-$37.92M+17.55%N/A
PACB$200.52M-$277.28M-$306.74M+20.59%N/A
ZIMV$457.43M-$246.16M-$393.28M-16.08%N/A
NPCE$65.42M-$22.83M-$32.96M+15.33%N/A
ANIK$166.66M-$71.19M-$82.67M+9.56%N/A

MXCT earnings dates

Next earnings date
May 7, 2024

Maxcyte Earnings & Revenue FAQ

What were MXCT's earnings last quarter?

On Invalid Date, Maxcyte (NASDAQ: MXCT) reported Q4 2023 earnings per share (EPS) of -$0.05, up 0% year over year. Total Maxcyte earnings for the quarter were -$5.28 million. In the same quarter last year, Maxcyte's earnings per share (EPS) was -$0.05.

If you're new to stock investing, here's how to buy Maxcyte stock.

What was MXCT's earnings growth in the past year?

As of Q2 2024, Maxcyte's earnings has grown year over year. Maxcyte's earnings in the past year totalled -$37.92 million.

What is MXCT's earnings date?

Maxcyte's earnings date is Invalid Date. Add MXCT to your watchlist to be reminded of MXCT's next earnings announcement.

What was MXCT's revenue last quarter?

On Invalid Date, Maxcyte (NASDAQ: MXCT) reported Q4 2023 revenue of $15.66 million up 26.09% year over year. In the same quarter last year, Maxcyte's revenue was $12.42 million.

What was MXCT's revenue growth in the past year?

As of Q2 2024, Maxcyte's revenue has grown -6.72% year over year. This is 15.97 percentage points lower than the US Medical Devices industry revenue growth rate of 9.25%. Maxcyte's revenue in the past year totalled $41.29 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.